Warfarin Increases Stroke Risk in Atrial Fibrillation Patients

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A study published in the European Heart Journal finds that atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy. Data on stroke incidence in patients newly diagnosed with atrial fibrillation was analyzed and each case of stroke was randomly matched with 10 controls. Stroke risk was significantly higher among patients who had begun taking warfarin within 30 days when compared with patients who had not used any antithrombotic therapy for at least 1 year. Patients taking warfarin had a lower risk for stroke when they had been taking the drug longer than 1 month.

To read the full article on HCPLive.com, click here.
Related Articles
Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.
Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.
Adults whose mothers were overweight or obese before pregnancy have a dramatically elevated risk of dying from heart disease or stroke, according to a new study presented at the American Heart Association’s Scientific Sessions 2014.
Andexanet alfa showed promise as an anti-Xa reversal agent in new research presented at the American Heart Association's Scientific Session 2014.
Latest Issues
$auto_registration$